Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernd Gerber

Showing results (151-160 of 173) with videos related to

Pageof 18
Sort By:
JAMA Oncology|July 18, 2017
Germline Mutation Status, Pathological Complete Response, and Disease-Free Survival in Triple-Negative Breast Cancer: Secondary Analysis of the GeparSixto Randomized Clinical TrialEric Hahnen, Bianca Lederer, Jan Hauke, et al.
Breast Care (Basel, Switzerland)|January 14, 2014
13th st. Gallen international breast cancer conference 2013: primary therapy of early breast cancer evidence, controversies, consensus - opinion of a german team of experts (zurich 2013)Michael Untch, Bernd Gerber, Nadia Harbeck, et al.
International Journal of Cancer|June 24, 2015
Genetic variants in VEGF pathway genes in neoadjuvant breast cancer patients receiving bevacizumab: Results from the randomized phase III GeparQuinto studyAlexander Hein, Diether Lambrechts, Gunter von Minckwitz, et al.
Lancet (London, England)|February 18, 2014
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysisPatricia Cortazar, Lijun Zhang, Michael Untch, et al.
Breast Care (Basel, Switzerland)|September 26, 2022
AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2022Marc Thill, Diana Lüftner, Cornelia Kolberg-Liedtke, et al.
Breast Care (Basel, Switzerland)|September 28, 2019
AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2019Marc Thill, Christian Jackisch, Wolfgang Janni, et al.
Breast Care (Basel, Switzerland)|August 11, 2020
AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2020Nina Ditsch, Michael Untch, Cornelia Kolberg-Liedtke, et al.
Geburtshilfe Und Frauenheilkunde|October 3, 2022
AGO Recommendations for the Surgical Therapy of Breast Cancer: Update 2022Maggie Banys-Paluchowski, Marc Thill, Thorsten Kühn, et al.
Breast Care (Basel, Switzerland)|September 28, 2019
AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2019Nina Ditsch, Michael Untch, Marc Thill, et al.
Geburtshilfe Und Frauenheilkunde|October 11, 2021
AGO Recommendations for the Surgical Therapy of the Axilla After Neoadjuvant Chemotherapy: 2021 UpdateMichael Friedrich, Thorsten Kühn, Wolfgang Janni, et al.
Pageof 18

Showing results (151-160 of 173) with videos related to

Sort By:
Pageof 18
JAMA Oncology|July 18, 2017
Germline Mutation Status, Pathological Complete Response, and Disease-Free Survival in Triple-Negative Breast Cancer: Secondary Analysis of the GeparSixto Randomized Clinical TrialEric Hahnen, Bianca Lederer, Jan Hauke, et al.
Breast Care (Basel, Switzerland)|January 14, 2014
13th st. Gallen international breast cancer conference 2013: primary therapy of early breast cancer evidence, controversies, consensus - opinion of a german team of experts (zurich 2013)Michael Untch, Bernd Gerber, Nadia Harbeck, et al.
International Journal of Cancer|June 24, 2015
Genetic variants in VEGF pathway genes in neoadjuvant breast cancer patients receiving bevacizumab: Results from the randomized phase III GeparQuinto studyAlexander Hein, Diether Lambrechts, Gunter von Minckwitz, et al.
Lancet (London, England)|February 18, 2014
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysisPatricia Cortazar, Lijun Zhang, Michael Untch, et al.
Breast Care (Basel, Switzerland)|September 26, 2022
AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2022Marc Thill, Diana Lüftner, Cornelia Kolberg-Liedtke, et al.
Breast Care (Basel, Switzerland)|September 28, 2019
AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2019Marc Thill, Christian Jackisch, Wolfgang Janni, et al.
Breast Care (Basel, Switzerland)|August 11, 2020
AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2020Nina Ditsch, Michael Untch, Cornelia Kolberg-Liedtke, et al.
Geburtshilfe Und Frauenheilkunde|October 3, 2022
AGO Recommendations for the Surgical Therapy of Breast Cancer: Update 2022Maggie Banys-Paluchowski, Marc Thill, Thorsten Kühn, et al.
Breast Care (Basel, Switzerland)|September 28, 2019
AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2019Nina Ditsch, Michael Untch, Marc Thill, et al.
Geburtshilfe Und Frauenheilkunde|October 11, 2021
AGO Recommendations for the Surgical Therapy of the Axilla After Neoadjuvant Chemotherapy: 2021 UpdateMichael Friedrich, Thorsten Kühn, Wolfgang Janni, et al.
Pageof 18